Stryker Corporation has reaffirmed its fiscal 2026 outlook, projecting net sales growth between 8.0% and 9.5%, despite a downward revision of its price target to $330. The company reported a 3.9% increase in international organic sales, and its stock currently trades at $306.76, reflecting a modest rise. Previously, Stryker delivered a strong fourth quarter in 2025, with an 11.4% revenue growth, leading to an 8.6% stock jump after reporting revenues of $7.17 billion. Despite mixed analyst ratings, the company maintains a solid growth forecast for the upcoming year.
Loading timeline…
